Reza Ghorbani

Reza Ghorbani MD, ABIPP, FIPP (born April 18, 1966) is an American Medical Doctor and the current President of the Advanced Pain Medicine Institute in Washington D.C.   He is also the founder of Truceuticals Inc., which produces Noxicare, a natural product designed for pain relief.

Dr. Ghorbani is known for his work in interventional pain relief medicine, and has been featured in several media outlets, including the New York Daily News.

Early life
Reza Ghorbani was born in Tehran, Iran, and lived there until he was 17. His parents then sent him to the United States to attend college at Tufts University, where he earned his bachelor’s degree in biology in 1987. He continued on to study at Tufts University School of Medicine, and earned his M.D. degree in 1992.

After completing medical school, Dr. Ghorbani completed a surgical internship at Tufts Medical School, then finished his residency in anesthesiology at Harvard’s Brigham and Women’s Teaching Hospital, followed by a fellowship in pain management at the same institution.

Career
Dr. Ghorbani began his career at Guardian Anesthesia Associates in 1997 before moving to Anesthesia Associates of Massachusetts, where he worked until 2007. In 2007, Ghorbani became the President and Medical Director of the Advanced Pain Medicine Institute in Chevy Chase, Maryland. He is currently the President and Medical Director of the institute, and he specializes in a variety of pain treatments, including lumbar epidural steroid injections and spinal cord stimulator implants.

In 2010, Ghorbani founded Truceuticals, a company dedicated to create natural pain relief medication. Truceuticals produces Noxicare, a formulation for relieving inflammation and pain, as well as a line of vitamins and antioxidants.

Reza Ghorbani is certified by the American Board of Anesthesiology with added qualifications in pain medicine and the American Board of Interventional Pain Physicians. He is also licensed to practice medicine in Washington D.C., Maryland, and California.